Roche (OTCMKTS:RHHBY) Share Price Crosses Below 50-Day Moving Average – Time to Sell?

Roche Holding AG (OTCMKTS:RHHBY) passed below its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of $50.77 and traded as low as $48.83. Roche shares last traded at $49.00, with a volume of 1,914,382 shares.

Analysts Set New Price Targets

A number of research firms have recently commented on RHHBY. TD Cowen reissued a “hold” rating on shares of Roche in a research note on Tuesday, February 10th. Morgan Stanley raised Roche from an “underweight” rating to an “equal weight” rating and set a $46.00 target price on the stock in a report on Friday, April 24th. Argus raised Roche from a “hold” rating to a “buy” rating in a report on Monday, April 6th. Finally, Wolfe Research restated an “outperform” rating on shares of Roche in a research note on Thursday, February 26th. Five equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to MarketBeat, the company has an average rating of “Hold” and an average price target of $51.50.

Roche Price Performance

The firm has a fifty day simple moving average of $50.77 and a two-hundred day simple moving average of $52.27. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.12 and a current ratio of 1.38.

Hedge Funds Weigh In On Roche

A number of institutional investors and hedge funds have recently modified their holdings of RHHBY. Oakworth Capital Inc. boosted its holdings in Roche by 20.8% during the 4th quarter. Oakworth Capital Inc. now owns 1,658 shares of the company’s stock valued at $86,000 after acquiring an additional 285 shares during the period. Enterprise Financial Services Corp raised its position in Roche by 6.6% during the 1st quarter. Enterprise Financial Services Corp now owns 5,576 shares of the company’s stock valued at $277,000 after purchasing an additional 345 shares in the last quarter. Archer Investment Corp raised its position in Roche by 7.7% during the 1st quarter. Archer Investment Corp now owns 5,598 shares of the company’s stock valued at $278,000 after purchasing an additional 398 shares in the last quarter. Diversified Trust Co raised its position in Roche by 0.8% during the 1st quarter. Diversified Trust Co now owns 59,375 shares of the company’s stock valued at $2,907,000 after purchasing an additional 448 shares in the last quarter. Finally, Fulton Bank N.A. raised its position in Roche by 4.6% during the 4th quarter. Fulton Bank N.A. now owns 11,659 shares of the company’s stock valued at $604,000 after purchasing an additional 508 shares in the last quarter.

About Roche

Roche Holding AG is a Swiss multinational healthcare company headquartered in Basel, founded in 1896 by Fritz Hoffmann‑La Roche. The company operates primarily through two complementary divisions — Pharmaceuticals and Diagnostics — and is known for integrating drug development with diagnostic capabilities to advance personalized healthcare. In the United States and other international markets, shares trade as American Depositary Receipts under the ticker RHHBY (OTCMKTS:RHHBY).

In pharmaceuticals, Roche focuses on developing and commercializing prescription medicines across therapeutic areas including oncology, immunology, infectious diseases and neuroscience, with a notable emphasis on targeted biologics and personalized therapies.